Cipla partners Premier Medical Corporation to launch COVID-19 rapid antigen test kits in India

"In this collaboration, Cipla will be responsible for the marketing and distribution of the Rapid Antigen Detection Test for the qualitative detection of SARS-CoV-2 antigen that will be manufactured by Premier Medical Corporation Pvt Ltd," Cipla said in a regulatory filing.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/37mR0yK
via IFTTT